Regeneration medtech company Tissue Regenix Group has agreed a deal with German distributor 2med GmbH.
It means the Hamburg-based operator, which specialises in products for the surgical and orthobiological treatments of the musculoskeletal system, will use Tissue Regenix's patented dCell technology in its OrthoPure XT which is used in cruciate and knee ligament reconstruction. At the moment, the multi-year deal covers Germany but there is potential for expansion into other territories that 2med covers.
Thomas Guenther, commercial director at 2med, said: "2med are delighted to be representing OrthoPure XT in Germany. The initial feedback from our knee surgeons is very positive and we are excited to offer this new, easy to use option for German patients with damaged ACL and other knee ligaments."
